Neuroblastoma originating from extra-abdominal sites: Association with favorable clinical and biological features

Journal of Korean Medical Science

Volumn 24, Issue 3, 2009, Pages 461-467

  Sung, Ki Woong ^a   Yoo, Keon Hee ^a   Koo, Hong Hoe ^a   Kim, Ju Youn ^a   Cho, Eun Joo ^a   Seo, Yeon Lim ^a   Kim, Jhingook ^a   Lee, Suk Koo ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Autologous; Neuroblastoma; Prognosis; Thorax; Transplantation

Indexed keywords

ENOLASE; FERRITIN; LACTATE DEHYDROGENASE; VANILMANDELIC ACID;

ARTICLE; BLOOD; DISEASE FREE SURVIVAL; FEMALE; HUMAN; MALE; NEUROBLASTOMA; PROGNOSIS; TREATMENT OUTCOME; URINE;

DISEASE-FREE SURVIVAL; FEMALE; FERRITINS; HUMANS; L-LACTATE DEHYDROGENASE; MALE; NEUROBLASTOMA; PHOSPHOPYRUVATE HYDRATASE; PROGNOSIS; TREATMENT OUTCOME; VANILMANDELIC ACID;

EID: 67649229501     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2009.24.3.461     Document Type: Article

References (29)

1. Evans AE, D'Angio GJ, Propert K, Anderson J, Hann HW. Prognostic factor in neuroblastoma. Cancer 1987; 59: 1853-9.
2. Coldman AJ, Fryer CJ, Elwood JM, Sonley MJ. Neuroblastoma: influence of age at diagnosis, stage, tumor site, and sex on prognosis. Cancer 1980; 46: 1896-901.
3. Matthay KK, Perez C, Seeger RC, Brodeur GM, Shimada H, Atkinson JB, Black CT, Gerbing R, Haase GM, Stram DO, Swift P, Lukens JN. Successful treatment of stage III neuroblastoma based on prospective biologic staging: a Children's Cancer Group study. J Clin Oncol 1998; 16: 1256-64.
4. Brodeur GM, Seeger RC, Schwab M, Varmus HE, Bishop JM. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science 1984; 224: 1121-4.
5. Seeger RC, Brodeur GM, Sather H, Dalton A, Siegel SE, Wong KY, Hammond D. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med 1985; 313: 1111-6.
6. Look AT, Hayes FA, Shuster JJ, Douglass EC, Castleberry RP, Bowman LC, Smith EI, Brodeur GM. Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: a Pediatric Oncology Group study. J Clin Oncol 1991; 9: 581-91.
7. Look AT, Hayes FA, Nitschke R, McWilliams NB, Green AA. Cellular DNA content as a predictor of response to chemotherapy in infants with unresectable neuroblastoma. N Engl J Med 1984; 311: 231-5.
8. Shimada H, Chatten J, Newton WA Jr, Sachs N, Hamoudi AB, Chiba T, Marsden HB, Misugi K. Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas. J Natl Cancer Inst 1984; 73: 405-16.
9. Shimada H, Ambros IM, Dehner LP, Hata J, Joshi VV, Roald B, Stram DO, Gerbing RB, Lukens JN, Matthay KK, Castleberry RP. The International Neuroblastoma Pathology Classification (the Shimada system). Cancer 1999; 86: 364-72.
10. Joshi VV, Cantor AB, Brodeur GM, Look AT, Shuster JJ, Altshuler G, Larkin EW, Holbrook CT, Silverman JF, Norris HT. Correlation between morphologic and other prognostic markers of neuroblastoma. A study of histologic grade, DNA index, N-myc gene copy number, and lactic dehydrogenase in patients in the Pediatric Oncology Group. Cancer 1993; 71: 3173-81.
11. Shuster JJ, McWilliams NB, Castleberry R, Nitschke R, Smith EI, Altshuler G, Kun L, Brodeur G, Joshi V, Vietti T. Serum lactate dehydrogenase in childhood neuroblastoma. A Pediatric Oncology Group recursive partitioning study. Am J Clin Oncol 1992; 15: 295-303.
12. Hann HW, Evans AE, Siegel SE, Wong KY, Sather H, Dalton A, Hammond D, Seeger RC. Prognostic importance of serum ferritin in patients with Stages III and IV neuroblastoma: the Childrens Cancer Study Group experience. Cancer Res 1985; 45: 2843-8.
13. Zeltzer PM, Marangos PJ, Sather H, Evans A, Siegel S, Wong KY, Dalton A, Seeger RC, Hammond D. Prognostic importance of serum neuron specific enolase in local and widespread neuroblastoma. Prog Clin Biol Res 1985; 175: 319-29.
14. Morris JA, Shochat SJ, Smith EI, Look AT, Brodeur GM, Cantor AB, Castleberry RP. Biological variables in thoracic neuroblastoma: a Pediatric Oncology Group study. J Pediatr Surg 1995; 30: 296-302.
15. Suita S, Tajiri T, Sera Y, Takamatsu H, Mizote H, Ohgami H, Kurosaki N, Hara T, Okamura J, Miyazaki S, Sugimoto T, Kawakami K, Tsuneyoshi M, Tasaka H, Yano H, Akiyama H, Ikeda K. The characteristics of mediastinal neuroblastoma. Eur J Pediatr Surg 2000; 10: 353-9.
16. Adams GA, Shochat SJ, Smith EI, Shuster JJ, Joshi VV, Altshuler G, Hayes FA, Nitschke R, McWilliams N, Castleberry RP. Thoracic neuroblastoma: a Pediatric Oncology Group study. J Pediatr Surg 1993; 28: 372-7.
17. Häberle B, Hero B, Berthold F, von Schweinitz D. Characteristics and outcome of thoracic neuroblastoma. Eur J Pediatr Surg 2002; 12: 145-50.
18. Horiuchi A, Muraji T, Tsugawa C, Nishijima E, Satho S, Takamizawa S, Misu H, Mabuchi O, Kanagawa K, Fujita M. Thoracic neuroblastoma: outcome of incomplete resection. Pediatr Surg Int 2004; 20: 714-8.
19. Cruccetti A, Kiely EM, Spitz L, Drake DP, Pritchard J, Pierro A. Pelvic neuroblastoma: low mortality and high morbidity. J Pediatr Surg 2000; 35: 724-8.
20. Moukheiber AK, Nicollas R, Roman S, Coze C, Triglia JM. Primary pediatric neuroblastic tumors of the neck. Int J Pediatr Otorhinolaryngol 2001; 60: 155-61.
21. Abramson SJ, Berdon WE, Ruzal-Shapiro C, Stolar C, Garvin J. Cervical neuroblastoma in eleven infants-a tumor with favorable prognosis. Clinical and radiologic (US, CT, MRI) findings. Pediatr Radiol 1993; 23: 253-7.
22. Berdon WE, Stylianos S, Ruzal-Shapiro C, Hoffer F, Cohen M. Neuroblastoma arising from the organ of Zuckerkandl: an unusual site with a favorable biologic outcome. Pediatr Radiol 1999; 29: 497-502.
23. Brodeur GM, Pritchard J, Berthold F, Carlsen NL, Castel V, Castleberry RP, De Bernardi B, Evans AE, Favrot M, Hedborg F, Kaneto M, Kemshead J, Lampert F, Lee RE, Look AT, Pearson AD, Philip T, Roald B, Sawada T, Seeger RC, Tsuchida Y, Voute PA. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol 1993; 11: 1466-77.
24. Sung KW, Lee SH, Yoo KH, Jung HL, Cho EJ, Koo HH, Lee SK, Kim J, Lim DH, Suh YL, Kim DW. Tandem high-dose chemotherapy and autologous stem cell rescue in patients over 1 year of age with stage 4 neuroblastoma. Bone Marrow Transplant 2007; 40: 37-45.
25. Matthay KK, Villablanca JG, Seeger RC, Stram DO, Harris RE, RamsayNK, Swift P, Shimada H, Black CT, Brodeur GM, Gerbing RB, Reynolds CP. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group. N Engl J Med 1999; 341: 1165-73.
26. Ladenstein R, Philip T, Lasset C, Hartmann O, Garaventa A, Pinkerton R, Michon J, Pritchard J, Klingebiel T, Kremens B, Pearson A, Coze C, Paolucci P, Frappaz D, Gadner H, Chauvin F. Multivariate analysis of risk factors in stage 4 neuroblastoma patients over the age of one year treated with megatherapy and stem-cell transplantation: a report from the European Bone Marrow Transplantation Solid Tumor Registry. J Clin Oncol 1998; 16: 953-65.
27. Berthold F, Boos J, Burdach S, Erttmann R, Henze G, Hermann J, Klingebiel T, Kremens B, Schilling FH, Schrappe M, Simon T, Hero B. Myeloablative megatherapy with autologous stem-cell rescue versus oral maintenance chemotherapy as consolidation treatment in patients with high-risk neuroblastoma: a randomized controlled trial. Lancet Oncol 2005; 6: 649-58.
28. George RE, Li S, Medeiros-Nancarrow C, Neuberg D, Marcus K, Shamberger RC, Pulsipher M, Grupp SA, Diller L. High-risk neuroblastoma treated with tandem autologous peripheral-blood stem cell-supported transplantation: long-term survival update. J Clin Oncol 2006; 24: 2891-6.
29. Kletzel M, Katzenstein HM, Haut PR, Yu AL, Morgan E, Reynolds M, Geissler G, Marymount MH, Liu D, Kalapurakal JA, Shore RM, Bardo DM, Schmoldt J, Rademaker AW, Cohn SL. Treatment of high-risk neuroblastoma with triple-tandem high-dose therapy and stem-cell rescue: results of the Chicago Pilot II Study. J Clin Oncol 2002; 20: 2284-92.